Bavarian Nordic AS - Company Profile
Powered by 
All the data and insights you need on Bavarian Nordic AS in one report.
$295
- Save hours of research time and resources with
our up-to-date Bavarian Nordic AS Strategy Report
- Understand Bavarian Nordic AS position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Bavarian Nordic AS’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Bavarian Nordic AS's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Luc Debruyne
Chairman Executive BoardMr. Luc Debruyne has been the Chairman of the company since 2023. Prior to this, he served as the Former President at Global Vaccines at GSK.
Paul Chaplin
Chief Executive Officer; President Senior ManagementMr. Paul Chaplin has been the President and Chief Executive Officer of Bavarian Nordic since 2014. Prior to this, he served as Executive Vice President of the company. Mr. Chaplin also worked for several years in the UK and Australia developing vaccines against infectious diseases.
Russell Thirsk
Chief Operating Officer; Executive Vice President Senior ManagementMr. Russell Thirsk has been the Executive Vice President and Chief Operating Officer of the company since April 2022. Prior to this, he served as Head of Operations at GSK Vaccines in Belgium.
Anu Helena Kerns
Chief People Officer; Executive Vice President Senior ManagementMrs. Anu Helena Kerns has been the Executive Vice President and the Chief People Officer of the company since 2020. Prior to this, she served held various leadership roles with increasing responsibilities in Novo Nordics. Ms. Kerns also worked in the financial sector with employer branding, reputation management and change communication.
Laurence De Moerlooze, Ph.D.
Executive Vice President; Chief Medical Officer Senior ManagementDr. Laurence De Moerlooze has been the Executive Vice President and the Chief Medical officer of the company since April 2020. Prior to this, she served as the Vice President and the Global Program Lead at Takeda Vaccines. Dr. Laurence also held various leading roles in medical affairs and vaccine development working with numerous life-saving vaccines including Encepur and Rabipur/Rabavert .
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer